| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655688 | Digestive and Liver Disease | 2017 | 6 Pages |
Abstract
We validated the extratumoral expression of CYP1A2 as a biomarker of HCC recurrence in HCV patients. CYP1A2 analysis in pretreatment liver biopsy can be of help to stratify HCC patients for personalized treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Amedeo Sciarra, Bogdan Pintea, Ji Hae Nahm, Matteo Donadon, Emanuela Morenghi, Marco Maggioni, Jean Frederic Blanc, Guido Torzilli, Matthew Yeh, Paulette Bioulac-Sage, Young Nyun Park, Massimo Roncalli, Luca Di Tommaso,